Orchard Therapeutics

Leslie Meltzer, Ph.D., Chief Medical Officer

Oct. 12 | 5:45pm | AVROBIO Ballroom

London, United Kingdom


Orchard Therapeutics is a global gene therapy leader dedicated to transforming the lives of people affected by severe diseases through the development of innovative, potentially curative gene therapies. Our ex vivo autologous gene therapy approach harnesses the power of genetically modified blood stem cells and seeks to correct the underlying cause of disease in a single administration.


By using this website you agree to accept our Privacy Policy and Terms & Conditions